Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Jason LA, Porter N, Hunnell J, Rademaker A, Richman JA. CFS prevalence and risk factors over time. J. Health Psychol. 16(3), 445–456 (2011).
  MedlineGoogle Scholar
• 2 Reyes M, Nisenbaum R, Hoaglin DC et al. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch. Intern. Med. 163(13), 1530–1536 (2003).
  MedlineGoogle Scholar
• 3 Brown MM, Bell DS, Jason LA, Christos C, Bell DE. Understanding long-term outcomes of chronic fatigue syndrome. J. Clin. Psychol. 68(9), 1028–1035 (2012).
  MedlineGoogle Scholar
• 4 Johnston SC, Brenu EW, Hardcastle SL, Huth TK, Staines DR, Marshall-Gradisnik SM. A comparison of health status in patients meeting alternative definitions for chronic fatigue syndrome/myalgic encephalomyelitis. Health Qual. Life Outcomes 12, 64 (2014).
  MedlineGoogle Scholar
• 5 Hatcher S, House A. Life events, difficulties and dilemmas in the onset of chronic fatigue syndrome: a case–control study. Psychol. Med. 33(7), 1185–1192 (2003).
  MedlineGoogle Scholar
• 6 Lin JS, Resch SC, Brimmer DJ et al. The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs. Cost Eff. Resour. Alloc. 9(1), 1 (2011).
  MedlineGoogle Scholar
• 7 Reynolds KJ, Vernon SD, Bouchery E, Reeves WC. The economic impact of chronic fatigue syndrome. Cost Eff. Resour. Alloc. 2(1), 4 (2004).
  MedlineGoogle Scholar
• 8 Jones JF, Lin JM, Maloney EM et al. An evaluation of exclusionary medical/psychiatric conditions in the definition of chronic fatigue syndrome. BMC Med. 7, 57 (2009).
  MedlineGoogle Scholar
• 9 Nater UM, Lin JM, Maloney EM et al. Psychiatric comorbidity in persons with chronic fatigue syndrome identified from the Georgia population. Psychosom. Med. 71(5), 557–565 (2009).
  MedlineGoogle Scholar
• 10 Carruthers BM, Van De Sande MI, De Meirleir KL et al. Myalgic encephalomyelitis: international consensus criteria. J. Intern. Med. 270(4), 327–338 (2011).
  Medline CASGoogle Scholar
• 11 Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 121(12), 953–959 (1994).
  Medline CASGoogle Scholar
• 12 Jason LA, Richman JA, Rademaker AW et al. A community-based study of chronic fatigue syndrome. Arch. Intern. Med. 159(18), 2129–2137 (1999).
  Medline CASGoogle Scholar
• 13 Bansal AS, Bradley AS, Bishop KN, Kiani-Alikhan S, Ford B. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav. Immun. 26(1), 24–31 (2012).
  Medline CASGoogle Scholar
• 14 De Vega WC, Herrera S, Vernon SD, McGowan PO. Epigenetic modifications and glucocorticoid sensitivity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). BMC Med. Genomics 10(1), 11 (2017). •• Describes immune sensitivity differences and potential epigenetic biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) diagnosis.
  MedlineGoogle Scholar
• 15 De Vega WC, Vernon SD, McGowan PO. DNA methylation modifications associated with chronic fatigue syndrome. PLoS ONE 9(8), e104757 (2014). • First DNA methylome study of peripheral blood mononuclear cells in ME/CFS, where immune cell regulation genes were shown to be significantly enriched in DNA methylation differences.
  MedlineGoogle Scholar
• 16 Naviaux RK, Naviaux JC, Li K et al. Metabolic features of chronic fatigue syndrome. Proc. Natl Acad. Sci. USA 113(37), e5472–e5480 (2016).
  Medline CASGoogle Scholar
• 17 Costa V, Aprile M, Esposito R, Ciccodicola A. RNA-Seq and human complex diseases: recent accomplishments and future perspectives. Eur. J. Hum. Genet. 21(2), 134–142 (2013).
  Medline CASGoogle Scholar
• 18 Stessman HA, Bernier R, Eichler EE. A genotype-first approach to defining the subtypes of a complex disease. Cell 156(5), 872–877 (2014).
  Medline CASGoogle Scholar
• 19 Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13(7), 484–492 (2012).
  Medline CASGoogle Scholar
• 20 Lam LL, Emberly E, Fraser HB et al. Factors underlying variable DNA methylation in a human community cohort. Proc. Natl Acad. Sci. USA 109(Suppl. 2), 17253–17260 (2012).
  Medline CASGoogle Scholar
• 21 Ernst C, McGowan PO, Deleva V, Meaney MJ, Szyf M, Turecki G. The effects of pH on DNA methylation state: in vitro and post-mortem brain studies. J. Neurosci. Methods 174(1), 123–125 (2008).
  Medline CASGoogle Scholar
• 22 Vilahur N, Baccarelli AA, Bustamante M et al. Storage conditions and stability of global DNA methylation in placental tissue. Epigenomics 5(3), 341–348 (2013).
  CASGoogle Scholar
• 23 Hebels DG, Georgiadis P, Keun HC et al. Performance in omics analyses of blood samples in long-term storage: opportunities for the exploitation of existing biobanks in environmental health research. Environ. Health Perspect. 121(4), 480–487 (2013).
  MedlineGoogle Scholar
• 24 Tost J. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. Mol. Biotechnol. 44(1), 71–81 (2010).
  Medline CASGoogle Scholar
• 25 Kerr JR, Petty R, Burke B et al. Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J. Infect. Dis. 197(8), 1171–1184 (2008). • ME/CFS subtyping study based on gene expression profiles.
  Medline CASGoogle Scholar
• 26 Zhang L, Gough J, Christmas D et al. Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. J. Clin. Pathol. 63(2), 156–164 (2010).
  Medline CASGoogle Scholar
• 27 Shimosako N, Kerr JR. Use of single-nucleotide polymorphisms (SNPs) to distinguish gene expression subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J. Clin. Pathol. 67(12), 1078–1083 (2014). • SNP validation of ME/CFS subtypes that were based on gene expression profiles.
  Medline CASGoogle Scholar
• 28 Aslakson E, Vollmer-Conna U, White PD. The validity of an empirical delineation of heterogeneity in chronic unexplained fatigue. Pharmacogenomics 7(3), 365–373 (2006).
  Google Scholar
• 29 Vollmer-Conna U, Aslakson E, White PD. An empirical delineation of the heterogeneity of chronic unexplained fatigue in women. Pharmacogenomics 7(3), 355–364 (2006). • ME/CFS subtyping study based on clinical measures of a hospital cohort.
  Google Scholar
• 30 Aslakson E, Vollmer-Conna U, Reeves WC, White PD. Replication of an empirical approach to delineate the heterogeneity of chronic unexplained fatigue. Popul. Health Metr. 7, 17 (2009).
  MedlineGoogle Scholar
• 31 Wang B, Mezlini AM, Demir F et al. Similarity network fusion for aggregating data types on a genomic scale. Nat. Methods 11(3), 333–337 (2014). •• Description of similarity network fusion method to identify subtypes based on an integration of biological and clinical data.
  Medline CASGoogle Scholar
• 32 Xu T, Le TD, Liu L, Wang R, Sun B, Li J. Identifying cancer subtypes from miRNA-TF-mRNA regulatory networks and expression data. PLoS ONE 11(4), e0152792 (2016).
  MedlineGoogle Scholar
• 33 Zhang D, Chen P, Zheng CH, Xia J. Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach. Oncotarget 7(4), 4298–4309 (2016).
  MedlineGoogle Scholar
• 34 Wen H, Liu Y, Rekik I et al. Combining disrupted and discriminative topological properties of functional connectivity networks as neuroimaging biomarkers for accurate diagnosis of early Tourette syndrome children. Mol. Neurobiol. 55(4), 3251–3269 (2017).
  MedlineGoogle Scholar
• 35 Jason LA, So S, Brown AA, Sunnquist M, Evans M. Test-retest reliability of the DePaul symptom questionnaire. Fatigue 3(1), 16–32 (2015).
  MedlineGoogle Scholar
• 36 De Vega WC, McGowan PO. The epigenetic landscape of myalgic encephalomyelitis/chronic fatigue syndrome: deciphering complex phenotypes. Epigenomics 9(11), 1337–1340 (2017).
  CASGoogle Scholar
• 37 Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann. Med. 33(5), 350–357 (2001).
  Medline CASGoogle Scholar
• 38 Wang D, Yan L, Hu Q et al. IMA: an R package for high-throughput analysis of Illumina's 450 K Infinium methylation data. Bioinformatics 28(5), 729–730 (2012).
  Medline CASGoogle Scholar
• 39 Aryee MJ, Jaffe AE, Corrada-Bravo H et al. Minfi: a flexible and comprehensive bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30(10), 1363–1369 (2014).
  Medline CASGoogle Scholar
• 40 Maksimovic J, Gordon L, Oshlack A. SWAN: subset-quantile within array normalization for Illumina Infinium HumanMethylation450 BeadChips. Genome Biol. 13(6), R44 (2012).
  MedlineGoogle Scholar
• 41 Sandoval J, Heyn H, Moran S et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 6(6), 692–702 (2011).
  Medline CASGoogle Scholar
• 42 Houseman EA, Accomando WP, Koestler DC et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 13, 86 (2012).
  MedlineGoogle Scholar
• 43 Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8(1), 118–127 (2007).
  MedlineGoogle Scholar
• 44 Dick KJ, Nelson CP, Tsaprouni L et al. DNA methylation and body-mass index: a genome-wide analysis. Lancet 383(9933), 1990–1998 (2014).
  Medline CASGoogle Scholar
• 45 Fraga MF, Ballestar E, Paz MF et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl Acad. Sci. USA 102(30), 10604–10609 (2005).
  Medline CASGoogle Scholar
• 46 Chen YA, Lemire M, Choufani S et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8(2), 203–209 (2013).
  Medline CASGoogle Scholar
• 47 Morris TJ, Beck S. Analysis pipelines and packages for Infinium HumanMethylation450 BeadChip (450 k) data. Methods 72, 3–8 (2015).
  Medline CASGoogle Scholar
• 48 Achard S, Delon-Martin C, Vertes PE et al. Hubs of brain functional networks are radically reorganized in comatose patients. Proc. Natl Acad. Sci. USA 109(50), 20608–20613 (2012).
  Medline CASGoogle Scholar
• 49 Shiga M, Takigawa I, Mamitsuka H. Annotating gene function by combining expression data with a modular gene network. Bioinformatics 23(13), i468–i478 (2007).
  Medline CASGoogle Scholar
• 50 Subramanian A, Tamayo P, Mootha VK et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102(43), 15545–15550 (2005).
  Medline CASGoogle Scholar
• 51 Buchwald D, Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch. Intern. Med. 154(18), 2049–2053 (1994).
  Medline CASGoogle Scholar
• 52 Meeus M, Nijs J. Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin. Rheumatol. 26(4), 465–473 (2007).
  MedlineGoogle Scholar
• 53 Johnson SK, Deluca J, Natelson BH. Personality dimensions in the chronic fatigue syndrome: a comparison with multiple sclerosis and depression. J. Psychiatr. Res. 30(1), 9–20 (1996).
  Medline CASGoogle Scholar
• 54 Dancey CP, Friend J. Symptoms, impairment and illness intrusiveness – their relationship with depression in women with CFS/ME. Psychol. Health 23(8), 983–999 (2008).
  MedlineGoogle Scholar
• 55 Maes M. Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms. Curr. Opin. Psychiatry 22(1), 75–83 (2009).
  MedlineGoogle Scholar
• 56 Van De Vosse E, Haverkamp MH, Ramirez-Alejo N et al. IL-12Rβ1 deficiency: mutation update and description of the IL12RB1 variation database. Hum. Mutat. 34(10), 1329–1339 (2013).
  Medline CASGoogle Scholar
• 57 Brenu EW, Staines DR, Marshall-Gradisbik SM. Methylation profile of CD4⁺ T cells in chronic fatigue syndrome/myalgic encephalomyelitis. J. Clin. Cell Immunol. 5, 228 (2014).
  Google Scholar
• 58 Morris G, Berk M, Galecki P, Maes M. The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Mol. Neurobiol. 49(2), 741–756 (2014).
  Medline CASGoogle Scholar
• 59 Loebel M, Strohschein K, Giannini C et al. Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome. PLoS ONE 9(1), e85387 (2014).
  MedlineGoogle Scholar
• 60 Mensah F, Bansal A, Berkovitz S et al. Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study. Clin. Exp. Immunol. 184(2), 237–247 (2016).
  Medline CASGoogle Scholar
• 61 Bradley AS, Ford B, Bansal AS. Altered functional B cell subset populations in patients with chronic fatigue syndrome compared with healthy controls. Clin. Exp. Immunol. 172(1), 73–80 (2013).
  Medline CASGoogle Scholar
• 62 Fluge O, Bruland O, Risa K et al. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLoS ONE 6(10), e26358 (2011).
  Medline CASGoogle Scholar
• 63 Gaunt TR, Shihab HA, Hemani G et al. Systematic identification of genetic influences on methylation across the human life course. Genome Biol. 17, 61 (2016).
  MedlineGoogle Scholar
• 64 McRae AF, Powell JE, Henders AK et al. Contribution of genetic variation to transgenerational inheritance of DNA methylation. Genome Biol. 15(5), R73 (2014).
  MedlineGoogle Scholar
• 65 Dowsett EG, Ramsay AM, McCartney RA, Bell EJ. Myalgic encephalomyelitis – a persistent enteroviral infection? Postgrad. Med. J. 66(777), 526–530 (1990).
  Medline CASGoogle Scholar
• 66 Twisk FNM. An accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome requires strict clinical case definitions and objective test methods. J. Med. Diagnost. Methods 5(2), 68–87 (2017).
  Google Scholar
• 67 Irlbeck DM, Vernon SD, McCleary KK et al. No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank. BMC Res. Notes 7, 461 (2014).
  MedlineGoogle Scholar
• 68 Whistler T, Taylor R, Craddock RC, Broderick G, Klimas N, Unger ER. Gene expression correlates of unexplained fatigue. Pharmacogenomics 7(3), 395–405 (2006).
  CASGoogle Scholar
• 69 Vgontzas AN, Papanicolaou DA, Bixler EO et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J. Clin. Endocrinol. Metab. 85(3), 1151–1158 (2000).
  Medline CASGoogle Scholar
• 70 Smith AK, Kilaru V, Klengel T et al. DNA extracted from saliva for methylation studies of psychiatric traits: evidence tissue specificity and relatedness to brain. Am. J. Med. Genet. B Neuropsychiatr. Genet. 168b(1), 36–44 (2015).
  MedlineGoogle Scholar
• 71 Cowen L, Ideker T, Raphael BJ, Sharan R. Network propagation: a universal amplifier of genetic associations. Nat. Rev. Genet. 18(9), 551–562 (2017).
  Medline CASGoogle Scholar
• 72 Lenzenweger MF. Endophenotype, intermediate phenotype, biomarker: definitions, concept comparisons, clarifications. Depress. Anxiety 30(3), 185–189 (2013).
  MedlineGoogle Scholar
• 73 Hallmayer JF, Kalaydjieva L, Badcock J et al. Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. Am. J. Hum. Genet. 77(3), 468–476 (2005).
  Medline CASGoogle Scholar
• 74 Morar B, Dragovic M, Waters FA, Chandler D, Kalaydjieva L, Jablensky A. Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition. Mol. Psychiatry 16(8), 860–866 (2011).
  Medline CASGoogle Scholar
• 75 Peter B, Matsushita M, Raskind WH. Motor sequencing deficit as an endophenotype of speech sound disorder: a genome-wide linkage analysis in a multigenerational family. Psychiatr. Genet. 22(5), 226–234 (2012).
  MedlineGoogle Scholar
• 76 Mcmanimen SL, Jason LA. Post-exertional malaise in patients with ME and CFS with comorbid fibromyalgia. SRL Neurol. Neurosurg. 3(1), 22–27 (2017).
  MedlineGoogle Scholar
• 77 White AT, Light AR, Hughen RW, Vanhaitsma TA, Light KC. Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls. Psychosom. Med. 74(1), 46–54 (2012).
  Medline CASGoogle Scholar